Mandate

Vinge advises Active Biotech on rights offering

February 15, 2018 Capital Markets and Public M&A

Active Biotech AB (publ) issues new shares with pre-emptive rights for the shareholders.

The Vinge team includes Erik Sjöman, Christian Lindhé, Astrid Karlsson and Jack Bengtsson.
 

Related

Vinge advises EQT in connection with the sale of Eton

Vinge has advised EQT VII in connection with its sale of Eton to a consortium of private investors.
July 01, 2025

Vinge advises Triton in connection with the acquisition of Prenax

Vinge has advised Triton Smaller Mid Cap Fund II in connection with the acquisition of Prenax from LBO France and certain minority shareholders.
July 01, 2025

Vinge advises Impilo on the establishment of Impilo Healthcare

Vinge has advised Impilo with regulatory advice on the establishment of Impilo Healthcare. The fund will have EUR 320m in commitments.
July 01, 2025